article thumbnail

Butterfly Network Partners with Mendaera to Co-Develop a ‘New Category of Robotics’

MedCity News

Butterfly Network announced a product co-development deal with surgical robotics startup Mendaera, in which the startup will build custom robotics around Butterfly’s ultrasound-on-a-chip technology to create a new system designed for better surgical precision and consistency.

article thumbnail

Advanced therapy collaboration network launched in Scotland

European Pharmaceutical Review

The Cell and Gene Therapy Catapult (CGT Catapult) , supported by Scotland’s national economic development agency, Scottish Enterprise, has launched a new cooperative network to foster collaboration and increase knowledge sharing across the Advanced Therapy Medicinal Products (ATMP) industry in Scotland.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Highlights from The Data Ecosystem in 2025

Prognos Health

Prognos CEO Sundeep Bhan was a featured panelist in a session titled The Data Ecosystem in 2025 , which also included leaders from CVS Health, Komodo Health, and Blue Health Intelligence Ⓡ (BHI Ⓡ ). ” The post Highlights from The Data Ecosystem in 2025 appeared first on Prognos Health.

article thumbnail

Big Data Steering Group to enhance data quality and discoverability under new workplan

European Pharmaceutical Review

The joint Big Data Steering Group of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) has published a third workplan, setting actions to be delivered by 2025. According to EMA, the new plan will further enhance the efficient integration of data analysis into the regulatory evaluation of medicinal products.

article thumbnail

EMA publishes mid-point regulatory science strategy report

European Pharmaceutical Review

The European Medicines Agency (EMA) has published a report summarising the mid-point achievements of its Regulatory Science Strategy (RSS) to 2025. Initially published in March 2020, the strategy provides a plan for advancing regulatory science over a five-year period.

article thumbnail

Amgen opens its most advanced manufacturing facility to date

European Pharmaceutical Review

“As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us address serious disease around the world with our innovative biomedicines.” ” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff.

article thumbnail

EMA Highlights Trial Innovation, Real-World Data Advances

Pharma Leaders

The European Medicines Agency (EMA) reported “remarkable” progress despite the pandemic in a mid-point assessment of its “Regulatory Science Strategy to 2025” to build a more adaptive regulatory system that will encourage innovation — including advances in clinical trials and a new real-world data (RWD) network.